Jcic Asset Management Inc. Bristol Myers Squibb CO Transaction History
Jcic Asset Management Inc.
- $225 Million
- Q3 2024
A detailed history of Jcic Asset Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jcic Asset Management Inc. holds 340 shares of BMY stock, worth $18,407. This represents 0.01% of its overall portfolio holdings.
Number of Shares
340
Previous 340
-0.0%
Holding current value
$18,407
Previous $14,000
21.43%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding BMY
# of Institutions
2,477Shares Held
1.51BCall Options Held
29.6MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.59 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.95 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.22 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.2 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...